Skip to main content
TipRanks
Go Ultimate75% OFF

GenSight Biologics SA (G49N) Drug Pipeline

1 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Gs010, Gs010 High Dose, Gs010 Low DoseLeber Hereditary Optic DiseasePhase IIRecruitingEfficacy and Safety Study of Bilateral IVT Injection of GS010 at Two Dose Levels in LHON PatientsDec 11, 2025―
Gs010, Sham Intravitreal InjectionLeber Hereditary Optic NeuropathyPhase IIICompletedRESCUE and REVERSE Long-term Follow-upJan 15, 2018―
Gene Therapy: Gs030-Dp And Medical Device: Gs030-MdNon-Syndromic Retinitis Pigmentosaphase1AndPhase2Active Not RecruitingDose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis PigmentosaOct 11, 2017―
Gs010Leber Hereditary Optic NeuropathyPhase IIICompletedEfficacy & Safety Study of Bilateral IVT Injection of GS010 in LHON Subjects Due to the ND4 Mutation for up to 1 YearSep 19, 2017―
Gs010, Sham Intravitreal InjectionOptic, Atrophy, Hereditary, LeberPhase IIICompletedEfficacy Study of GS010 for Treatment of Vision Loss From 7 Months to 1 Year From Onset in LHON Due to the ND4 Mutation (REVERSE)Jan 07, 2016―
Gs010, Sham Intravitreal InjectionOptic, Atrophy, Hereditary, LeberPhase IIICompletedEfficacy Study of GS010 for the Treatment of Vision Loss up to 6 Months From Onset in LHON Due to the ND4 MutationJan 07, 2016―
Gs010Leber Hereditary Optic Neuropathyphase1AndPhase2CompletedSafety Evaluation of Gene Therapy in Leber Hereditary Optic Neuropathy (LHON) PatientsFeb 13, 2014―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does GenSight Biologics (DE:G49N) have in its pipeline
GenSight Biologics SA DE:G49N is currently developing the following drugs: Gs010, Gs010 High Dose, Gs010 Low Dose, Gs010, Sham Intravitreal Injection, Gene Therapy: Gs030-Dp And Medical Device: Gs030-Md, Gs010. These drug candidates are in various stages of clinical development as the company works toward FDA approval.